Remeron and Urinary frequency aggravated - a phase IV clinical study of FDA data

Summary:

Urinary frequency aggravated is reported as a side effect among people who take Remeron (mirtazapine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Lorazepam,.

The phase IV clinical study analyzes which people have Urinary frequency aggravated when taking Remeron. It is created by eHealthMe based on reports of 24,977 people who have side effects when taking Remeron from the FDA, and is updated regularly.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,475 Remeron users. Check the latest studies of Remeron.

What is Urinary frequency aggravated?

Urinary frequency aggravated is found to be associated with 313 drugs and 54 conditions by eHealthMe. Check the latest studies of Urinary frequency aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

24,977 people reported to have side effects when taking Remeron.
Among them, 13 people (0.05%) have Urinary frequency aggravated.

Could Remeron cause Urinary frequency aggravated?

Among these 13 people:

How long have people been on Remeron when they have Urinary frequency aggravated? *

What is the gender of people who have Urinary frequency aggravated when taking Remeron? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Urinary frequency aggravated when taking Remeron? *

What are other drugs people take besides Remeron? *

What are other side effects people have besides Urinary frequency aggravated? *

Joint Pain: 2 people, 15.38%
Oedema Lower Limb (fluid collection in tissue of lower leg): 2 people, 15.38%
Fatigue (feeling of tiredness): 2 people, 15.38%
Initial Insomnia (feeling of inadequate or poor-quality sleep): 1 person, 7.69%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 7.69%
Completed Suicide (act of taking one's own life): 1 person, 7.69%
Constipation: 1 person, 7.69%
Depressed Mood: 1 person, 7.69%
Dizziness (Excl Vertigo): 1 person, 7.69%
Drug Hypersensitivity: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Remeron and have Urinary frequency aggravated?

- Check whether Urinary frequency aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remeron:

Remeron (26,475 reports)

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary frequency aggravated:

Urinary frequency aggravated (313 drugs)

Browse all the conditions that are associated with Urinary frequency aggravated:

Urinary frequency aggravated (54 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Remeron) and Remeron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.